Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

By Kyvernitakis I.   Knöll D.   Struck M.   Hars O.   Bauer T.   Hadji P.  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite

Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials

By Markopoulos Christos  

Cancer and Metastasis Reviews, Vol. 29, Iss. 4, 2010-12 ,pp. : 581-594

Springer Publishing Company

Access to resources Recommend Favorite

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

By Jonat Walter   Hilpert Felix  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 6, 2006-06 ,pp. : 343-355

Springer Publishing Company

Access to resources Recommend Favorite

Strategies to Decrease Taxanes Toxicities in the Adjuvant Treatment of Early Breast Cancer

By Tang Shou-Ching  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 206-214

Informa Healthcare

Access to resources Recommend Favorite

The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer

By Londen G.  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 441-446

Springer Publishing Company

Access to resources Recommend Favorite